Zobrazeno 1 - 10
of 15
pro vyhledávání: '"R E, Drusin"'
Publikováno v:
Transplantation proceedings. 34(5)
Autor:
S S, Cook, R E, Drusin
Publikováno v:
NHC perspectives on community : official publication of the National League for Nursing. 16(5)
Autor:
T J, Garrett, A, Chadburn, M L, Barr, R E, Drusin, J M, Chen, L L, Schulman, C R, Smith, D S, Reison, E A, Rose, R E, Michler
Publikováno v:
Cancer. 72(9)
Posttransplantation lymphoproliferative disorders after solid organ transplantation are a serious complication occurring in 1-10% of patients. Different therapies have been used, but the optimal treatment is unknown. There is relatively little inform
Publikováno v:
Clinical Cardiology. 2:40-42
Following the development of digoxin radioimmunoassay, we noted that serum digoxin concentrations appeared to rise in patients given quinidine. To further evaluate this important possible interaction between digoxin and quinidine, charts from 863 car
Publikováno v:
Clinical cardiology. 2(1)
Following the development of digoxin radioimmunoassay, we noted that serum digoxin concentrations appeared to rise in patients given quinidine. To further evaluate this important possible interaction between digoxin and quinidine, charts from 863 car
Autor:
R E, Drusin
Publikováno v:
Medical times. 103(2)
Publikováno v:
ASAIO transactions. 34(1)
Cardiac allotransplantation is no longer experimental. It is the standard by which all other methods of cardiac replacement must be judged. The dramatic improvement in survival and the quality of life of cardiac transplant recipients reflects many fa
Autor:
L J, Addonizio, W M, Gersony, R C, Robbins, R E, Drusin, C R, Smith, D S, Reison, K, Reemtsma, E A, Rose
Publikováno v:
Circulation. 76(5 Pt 2)
Severe elevation of pulmonary vascular resistance has been considered a contraindication to cardiac transplantation. Most centers exclude patients with pulmonary vascular resistance greater than 6 Wood units. Wood units, however, do not correct for v
Autor:
R E, Michler, C R, Smith, R E, Drusin, D S, Reison, T J, Hickey, J, Lamb, K, Reemtsma, E A, Rose
Publikováno v:
Circulation. 74(5 Pt 2)
Although cyclosporine has decreased the severity of acute cardiac transplant rejection, most centers have continued to use high-dose intravenous steroids to treat acute rejection. To minimize the morbidity of antirejection therapy, acute rejection ep
Publikováno v:
Circulation. 72(3 Pt 2)
Despite the introduction of cyclosporine immunosuppression, infectious morbidity and mortality in cardiac transplant recipients has remained high. To decrease infectious complications, lower doses of cyclosporine and oral prednisone than previously r